| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.28 | 7e-20 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-16 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-16 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-16 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-15 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-15 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-14 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-14 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-14 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-13 |